|
News
17/12/2009
Merck & Co, Inc to Acquire Avecia Biologics
02/12/2009
Avecia Biologics customer achieves FDA approval
29/05/2009
BioProcess Scale-up : Product & Process Development Interactions
13/05/2009
Avecia launches Toolkit for production of Antibody Fragments
13/05/2009
MHRA Manufacturing Licence for Avecia Biologics
19/01/2009
Avecia Biologics has announced it has successfully undergone its first FDA Pre-Approval Inspection
16/12/2008
Avecia Biologics marks 10 years of Biopharmaceutical manufacture
05/08/2008
New Appointments at Avecia Biologics
25/07/2008
Listen to audio podcast of Andy Topping, PhD, R&D Director of Early Phase Development, recorded by BioPharm International at the BIO International Convention in San Diego, 16-20 June 2008
25/06/2008
MolMed and Avecia announce pharmaceutical development and manufacturing agreement
09/06/2008
Avecia adds Formulation Studies to its portfolio of services
09/06/2008
Avecia Biologics passes 2m hours without Lost Time Accident
15/05/2008
Avecia leads the way in development and manufacture of yeast-based biologics
20/03/2008
Avecia Announces sale of Vaccines Business to PharmAthene
09/10/2007
Barofold and Avecia announce development and manufacturing agreement.
03/10/2007
Listen to Steve Bagshaw, Business director, talk about Avecia's large scale manufacturing capabilities.
02/10/2007
pAVEway™ makes its mark as Avecia makes £1M investment to meet demand.
02/10/2007
Avecia and Renovo announce development and manufacturing agreement.
05/06/2007
Listen to Bo Kara, Director of Science & Technology, talk about the benefits of pAVEway™.
03/05/2007
Avecia launches pAVEway™ – advanced protein expression for the manufacture of biopharmaceuticals.
04/03/2007
Dr Kevin Cox talks to the Daily Telegraph about his role President of Avecia Biologics and as UK Trade & Industry's Chair of the Pharmaceutical and Biotechnology Sector.
03/01/2007
Avecia president named as government sector advisory group chair.
31/10/2006
Avecia and Illumigen Biosciences announce development & manufacturing agreement
24/04/2006
Avecia leads wound healing bio-processing team
|
|
